ロード中...
Thoracic perfusion of recombinant human endostatin (Endostar) combined with chemotherapeutic agents versus chemotherapeutic agents alone for treating malignant pleural effusions: a systematic evaluation and meta-analysis
BACKGROUND: Endostar is a new endogenous angiogenic inhibitor with implicated anti-tumor activity. This study was to investigate whether thoracic perfusion of Endostar could be used to control malignant pleural effusions (MPE). METHODS: We searched the databases of MEDLINE, Web of Science, EMBASE, G...
保存先:
| 出版年: | BMC Cancer |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5109813/ https://ncbi.nlm.nih.gov/pubmed/27842514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2935-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|